Literature DB >> 30730329

Very late recurrence of iris melanoma: 45 years after treatment.

Francesca Bosello1,2, Rana'a T Al-Jamal1,3,4, Victoria M L Cohen5,1,3.   

Abstract

Iris melanoma is a rare tumour that accounts for ~3-4% of all uveal melanoma cases. In the past, surgical resection was the sole treatement option, whereas nowadays, it has been replaced by brachytherapy as treatment of choice. Surgical resection is still in use in selected cases but combined with adjuvant radiotherapy in cases of incomplete resection. Herein, we report the case of a very late recurrence, 45 years after surgical resection. A literature review was performed to detect the latest recurrence reported to date and to understand the etiology behind very late recurrences. The role of multiple factors is discussed to explain this extremely delayed growth.

Entities:  

Mesh:

Year:  2020        PMID: 30730329     DOI: 10.1097/CMR.0000000000000581

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  3 in total

1.  Recurrent melanoma arising from sclera.

Authors:  Hillary C Stiefel; Audra Miller; David J Wilson; Daniel M Albert
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-05

2.  Delayed recurrence of an iridociliary malignant melanoma 180° from the primary tumor.

Authors:  Nikolas S Hopkins; Ilyse S Kornblau; Christopher E Montes-Sabino; Alan Boom; Matthew W Wilson
Journal:  Am J Ophthalmol Case Rep       Date:  2022-10-07

3.  Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma.

Authors:  Valerie Schmelter; Sarah Heidorn; Alexander Muacevic; Siegfried G Priglinger; Paul Foerster; Raffael Liegl
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.